Evaluation of a Smartphone Based Diagnostic Tool to Assess Neonatal Jaundice in a Mexican Population
1 other identifier
interventional
174
1 country
1
Brief Summary
This corss-sectional study aims to test the performance and accuracy of the Picterus JP screening device in newborns with different skin types.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 11, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
August 8, 2018
CompletedFirst Submitted
Initial submission to the registry
November 8, 2022
CompletedFirst Posted
Study publicly available on registry
November 21, 2022
CompletedNovember 21, 2022
November 1, 2022
10 days
November 8, 2022
November 18, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Enable high qualitative estimation of bilirubin levels in the blood of newborns using Picterus JP
Evaluate of smartphone-based diagnostic tool (Picterus JP) for neonatal jaundice in newborns.
6 months
Secondary Outcomes (3)
Correlation with TsB
1-2 hours
Correlation with TcB
5-10 minutes
Correlation with visual assessment
5-10 minutes
Study Arms (1)
Enable high qualitative estimation of bilirubin levels in the blood of new-borns
EXPERIMENTALThere is only one arm in this study which is to enable high qualitative estimation of bilirubin levels in the blood of new-borns, independent of skin color, using Picterus JP.
Interventions
Use Picterus Jaundice Pro, a smartphone app that is used to take photo of the newborns skin, where the Picterus calibration card is place.
Eligibility Criteria
You may qualify if:
- Healthy newborns with or without signs of jaundice
- Gestational age \>35 weeks
- Age 0-14 days
- Birth weight \> 1500 g.
- Parents acceptance of their children to participate in the study.
- Newborn needing a blood test
You may not qualify if:
- Newborns showing signs or with diagnosis of inborn diseases
- Newborn transferred to pediatric ward for any treatment
- Newborns who had received phototherapy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital Materno- Infantil de Irapuato
Irapuato, Guanajuato, 36546, Mexico
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Elisabeth Darj, Prof, MD, PhD
NTNU Faculty of Medicine and Health Sciences, Department of Public Health and Nursing
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 8, 2022
First Posted
November 21, 2022
Study Start
July 1, 2018
Primary Completion
July 11, 2018
Study Completion
August 8, 2018
Last Updated
November 21, 2022
Record last verified: 2022-11
Data Sharing
- IPD Sharing
- Will not share